Lisa Lindfors

Ms. Lisa Lindfors

Faculty of Science and Engineering, Åbo Akademi University, Turku, Varsinais-Suomi, Finland
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ESErica Sjöholm
Erica Sjöholm
RMRathna Mathiyalagan
Rathna Mathiyalagan
DPDhayakumar Rajan Prakash
Dhayakumar Rajan Prakash
LLLisa Lindfors
Lisa Lindfors
QWQingbo Wang
Qingbo Wang
NSNiklas Sandler
Niklas Sandler
Currently, the number of approved veterinary medicines are limited, and human medications are used off-label. These approved human medications are of too high potencies for a cat or a small dog breed. Therefore, there is a dire demand for smaller doses of veterinary medicines. This study aims to investigate the use of three semi-solid extrusion 3D printers in a pharmacy or animal clinic setting for the extemporaneous manufacturing of prednisolone containing orodispersible films for veterinary use. Orodispersible films with adequate content uniformity and acceptance values as defined by the European Pharmacopoeia were produced with one of the studied printers, namely the Allevi 2 bioprinter. Smooth and flexible films with high mechanical strength, neutral pH, and low moisture content were produced with a high correlation between the prepared design and the obtained drug amount, indicating that the Allevi 2 printer could successfully be used to extemporaneously manufacture personalized doses for animals at the point-of-care.

17 April 2022 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
ESErica Sjöholm
Erica Sjöholm
RMRathna Mathiyalagan
Rathna Mathiyalagan
LLLisa Lindfors
Lisa Lindfors
XWXiaoju Wang
Xiaoju Wang
SOSamuli Ojala
Samuli Ojala
NSNiklas Sandler
Niklas Sandler
Currently, there are a few or none marketed gabapentin veterinary products, leading to treatment with compounded dosage forms or off-label use of human-marketed products. With the said approaches, there are significant risks of preparation errors, rendering these practices suboptimal. A new manufacturing technique to accurately and rapidly prepare veterinary dosage forms close to the point-of-care is needed. However, a current hurdle in developing small-dose gabapentin dosage forms is the quantification of the gabapentin molecule. UV-Vis spectrophotometric quantification possesses suitable properties for implementation at small production sites, but quantifying gabapentin with the said technique has proven to be challenging as the small molecule lacks chromophores. This study aimed at thoroughly assessing UV-Vis spectrophotometric gabapentin quantification methods with the intent of finding a reliable method. Excellent linearity (R2 = 0.9998) in a broad and useful concentration range (0.5-40 µg/mL) was detected for the ascorbic acid derivatization method at a wavelength of 376 nm. The method was successfully applied to determine the drug content in the prepared semi-solid extrusion 3D-printed dosage forms. This study proved that pet-friendly tailored gabapentin dosage forms could easily be manufactured by semi-solid extrusion 3D printing and UV-Vis spectrophotometrically analyzed with the ascorbic acid derivatization method.